Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
| Image |  |
|---|---|
| Description | scientific article published on 30 April 2020 |
| Author/s |
author: Paweł Grieb Konrad Rejdak |
| Publication date | April 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |